Extended Data Fig. 5: TCR-seq analysis of tumor-infiltrating TREG and TFR cells.
From: Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy

a, the pie chart illustrates the mean percentage of TFR clonotypes that were shared with TREG cells (light blue) and non-TREG cells (gray) respectively, from 4 patients with the highest numbers of clonally expanded FOXP3-expressing cells from a published single-cell RNA-seq dataset20. The lower panel plot displays the percentage of TFR clonotypes that overlap with 4-1BB– or 4-1BB+ tumor-infiltrating TREG cells. b, Euler diagram depicting the degree of clonal overlap between TREG, TFH and TFR cells. c, Representative TraCer plot of patient 101020 depicting all clonally expanded cells, color indicates the type of tumor-infiltrating CD4+ T cells: non-TREG (gray, FOXP3–), 4-1BB– TREG (green), 4-1BB+ TREG (red) and TFR (yellow) cells. d, Single-cell pseudotime trajectory of 4-1BB–, 4-1BB+ TREG, clonally expanded, TCR-sharing TREG and TFR cells (indicated with colored circles) constructed using the Monocle3 algorithm. e, Correlation of Monocle component 1 (x-axis) with the genes commonly unregulated in 4-1BB+ TREG, clonally expanded, TCR-sharing TREG and TFR cells compared to 4-1BB– TREG cells (y-axis). The solid line represents LOESS fitting between the shared signature and Monocle component 1. f, flow cytometric analysis of the frequency (left panel, P = 0.002 for indicated comparison), MFI (middle panel, P = 0.002 for indicated comparison) for 4-1BB expression in tumor-infiltrating CD8+ T cells, TREG and TFR cells (n = 10 treatment naïve NSCLC patients as in Fig. 2a–d). Data are mean + /− s.e.m. Significance for comparisons were computed using two-tailed Wilcoxon matched-pairs signed-rank test between TREG and TFR cells.